I kēia mau lā, ua hana ʻo Nantong Chanyoo i kahi mea nui i ka mōʻaukala!Me nā hoʻoikaika ʻana no hoʻokahi makahiki, ua ʻae ʻia ka KDMF mua o Chanyoo e MFDS.ʻO ka mea hana nui loa o Rosuvastatin Calcium ma Kina,makemake mākou e wehe i kahi mokuna hou ma ka mākeke Korea.A e hoʻokuʻu ʻia nā huahana hou aʻe i nā makahiki e hiki mai ana.

Eia kekahi, hiki iā ʻoe ke nānā a loaʻa i kā mākou ʻike mai kēia pūnaewele:

https://nedrug.mfds.go.kr/pbp/CCBAC03

He kūpono ʻo Rosuvastatin calcium no ka mālama ʻana i nā mea maʻi me ka hypercholesterolemia mua (type IIa, me ka heterozygous familial hypercholesterolemia) a i ʻole lipemia i hui pū ʻia (type IIb) inā ʻaʻole kūpono ka meaʻai a i ʻole ka hoʻomaʻamaʻa ʻana.ʻO ka calcium ʻo Rosuvastatinhe mea koho 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor.Ma ke kaohi ʻana i ka HMG-CoA reductase, hoʻemi ia i ka hoʻohui ʻana o ke akepaʻa a me ka mālama ʻana i ka cholesterol, a laila e hoʻohaʻahaʻa i ke koko holoʻokoʻa cholesterol (TC) a me ka lipoprotein cholesterol haʻahaʻa haʻahaʻa (LDL-C).

Wahi a ka ʻikepili Newport, mai Iune 30, 2018 a i Iune 30, 2019, ʻo ke kūʻai aku ʻana o ka hoʻomākaukau calcium rosuvastatin i ka honua he US $ 3.461 biliona, ka emi ʻana o ka makahiki he 13%;ʻO ke kūʻai aku ʻana o ka honua o ka rosuvastatin calcium maka he 151.09 tons, ʻo ka piʻi ʻana o ka makahiki he 14%

mākou,Hale Hana Laau Laau o Changzhou(mea hana waiwai: Nantong Chanyoo Pharmatech Co., Ltd.) hāʻawi iā mākou iho i ka mea hoʻolako nui loa o Rosuvastatin API.